Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

380 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 380 results

Testing effectiveness (Phase 2)Study completedNCT02072863
What this trial is testing

Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 9
Testing effectiveness (Phase 2)Study completedNCT02891811
What this trial is testing

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

Who this might be right for
Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 124
Large-scale testing (Phase 3)Study completedNCT01850524
What this trial is testing

IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 705
Testing effectiveness (Phase 2)Study completedNCT00750815
What this trial is testing

Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 58
Testing effectiveness (Phase 2)Looking for participantsNCT07107529
What this trial is testing

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Who this might be right for
Multiple Myeloma (MM)
European Myeloma Network B.V. 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT05231629
What this trial is testing

Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 300
Large-scale testing (Phase 3)Looking for participantsNCT06182774
What this trial is testing

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Canadian Cancer Trials Group 570
Testing effectiveness (Phase 2)Study completedNCT02441686
What this trial is testing

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)Study completedNCT01237249
What this trial is testing

Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 250
Early research (Phase 1)Looking for participantsNCT07652138
What this trial is testing

Safety and Efficacy of RN1201 Injection as First-Line Treatment for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MylomaNewly Diagnosed Multiple Myeloma (NDMM)
The First Affiliated Hospital of Soochow University 18
Large-scale testing (Phase 3)Looking for participantsNCT07297329
What this trial is testing

Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Who this might be right for
Multiple Myeloma (MM)
Sinocelltech Ltd. 292
Not applicableLooking for participantsNCT06497738
What this trial is testing

A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University 112
Testing effectiveness (Phase 2)WithdrawnNCT01055301
What this trial is testing

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT01341262
What this trial is testing

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 378
Large-scale testing (Phase 3)Active Not RecruitingNCT04923893
What this trial is testing

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 743
Testing effectiveness (Phase 2)Active Not RecruitingNCT03989414
What this trial is testing

Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma
Celgene 424
Large-scale testing (Phase 3)UnknownNCT01532856
What this trial is testing

Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years

Who this might be right for
Multiple Myeloma
Grupo de Estudos Multicentricos em Onco-Hematologia 64
Large-scale testing (Phase 3)Looking for participantsNCT07285239
What this trial is testing

Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
PrECOG, LLC. 500
Very early researchUnknownNCT05840107
What this trial is testing

Study of FasT CAR-T GC012F Injection NDMM Patients

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 18
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Next Page